In 2010, the scientific and business landscape of drug development was fraught with continued uncertainty and risk. New paradigms for discovering and developing drugs were sought to bridge the ever-widening gap between scientific discoveries and translation of those discoveries into life-changing medications. The landscape of the drug development enterprise was increasingly global, with an attending need to address cross-border issues in the regulatory, scientific, ethical, and economic arenas.
The activities of the National Academies’ Forum on Drug Discovery, Development, and Translation (the Forum) in 2010 reflected this dynamic environment, focusing on five critical areas:
- Addressing the Approach to Drug Development: Problems and Opportunities
- Promoting and Enhancing the Scientific Basis for the Regulation of Drugs
- Transforming Research and Fostering Collaborative Research
- Developing Drugs for Rare and Neglected Diseases and Addressing Urgent Global Health Problems
- Promoting Public Understanding of Drug Development
For more information, please see https://www.nationalacademies.org/our-work/forum-on-drug-discovery-development-and-translation.